Welcome to MyStrategist

Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today

Subscribe Browse

Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review

Start a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways

Start Trial

Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Providers & Payors

Type 2 Diabetes, Dental, MSK Top US Healthcare Spending

The first comprehensive, data-based analysis of US spending on healthcare by condition, an ongoing project of the Institute for Health Metrics and Evaluation at the University of Washington, aims to provide a more accurate assessment of US spending per disease, with potential to inform policy, industry, insurers, and other stakeholders. It concludes, to the surprise of some, we spend the most on type 2 diabetes, followed by musculoskeletal disorders and oral dental care.

Don't Just Advertise... Strategize!

Advertise with MedTech Strategist and be seen by medtech's most influential executives.

Learn More

Latest from Community Blog

MedTech Strategist's free Community Blog explores the passion behind the people, technologies, and companies impacting the global device space.

Our strategic publications provide actionable intelligence to support each member of your organization. Check to see if your company has access.

Learn More